<!DOCTYPE html>
<html>
    <head>
        </meta charset="UTD-8">
        <title>COVID-19åœ‹å…§ç–«æƒ…å„€éŒ¶æ¿-æœ€æ–°æ–‡ç»èˆ‡æ¨æ–‡</title>
    </head>
    <body>
        <!--å›åˆ°é¦–é -->
        <a href="https://boyuan0926.github.io/Final-Report/"><img src="Home.jpg" width="50"></a>

        <h2>é†«å­¸èˆ‡ç”Ÿç‰©COVID-19æ–‡ç»å°ˆå€</h2>
        <ul type="circle">
            <li><a href="https://www.nejm.org/coronavirus">The New England Journal of Medicine</a></li>
            <li><a href="https://www.thelancet.com/coronavirus">Lancet</a></li>
            <li><a href="https://jamanetwork.com/journals/jama/pages/coronavirus-alert">JAMA</a></li>
            <li><a href="https://www.bmj.com/coronavirus">The BMJ</a></li>
            <li><a href="https://www.nature.com/subjects/sars-cov-2">Nature</a></li>
            <li><a href="https://www.cell.com/COVID-19">Cell</a></li>
            <li><a href="https://www.science.org/collections/coronavirus">Science</a></li> 
            <li><a href="http://connect.biorxiv.org/relate/content/181">medRxiv and bioRxiv</a></li>
            <li><a href="https://www.ssrn.com/index.cfm/en/coronavirus/">SSRN</a></li></ul>
        
        <h2>COVID-19é‡è¦æ¨æ–‡å°ˆå€</h2>
            <blockquote class="twitter-tweet"><p lang="en" dir="ltr">NEWSğŸ“¢Our latest data shows booster doses are continuing to provide high levels of protection against severe disease from the Omicron variant among older adults. <a href="https://t.co/dlt3EPYfm0">pic.twitter.com/dlt3EPYfm0</a></p>&mdash; UK Health Security Agency (@UKHSA) <a href="https://twitter.com/UKHSA/status/1479526192428503044?ref_src=twsrc%5Etfw">January 7, 2022</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
            <blockquote class="twitter-tweet"><p lang="en" dir="ltr">Most of the Omicron 2 &amp; 3-dose vaccine effectiveness (VE) data has been w/ Pfizer. A new <a href="https://twitter.com/KPSCalResearch?ref_src=twsrc%5Etfw">@KPSCalResearch</a> report on Moderna, for Omicron and Delta<a href="https://t.co/e8ZwaemJ3S">https://t.co/e8ZwaemJ3S</a><br>vs Omicron infection<br>VE 2-dose (graph)<br>VE 3-dose 62% (95% CI 56,68)<br>Lower: earlier boost; immunocompromised <a href="https://t.co/y2okNPoFdA">pic.twitter.com/y2okNPoFdA</a></p>&mdash; Eric Topol (@EricTopol) <a href="https://twitter.com/EricTopol/status/1479838865003212802?ref_src=twsrc%5Etfw">January 8, 2022</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
            <blockquote class="twitter-tweet"><p lang="en" dir="ltr">Today we publish our latest analysis where we stratify by age to investigate vaccine effectiveness (VE) against Omicron in adults aged 65 years and older in England. <a href="https://t.co/y73uto6kll">https://t.co/y73uto6kll</a><br><br>1/14</p>&mdash; Freja Kirsebom (@freja_kirsebom) <a href="https://twitter.com/freja_kirsebom/status/1479528228079509516?ref_src=twsrc%5Etfw">January 7, 2022</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
    </body>
</html>
